Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JDOC vs. QAAGZX: which is better?

Bottom line

JDOC vs QAAGZX: the short answer

JDOC (JPMorgan Healthcare Leaders ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 58% by weight.

But QAAGZX is far broader, holding 277 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.

JDOC is cheaper at 0.65% vs 0.86% — a difference of $21 a year per $10,000 invested.

Over one year, QAAGZX returned +18.1% vs +14.9% for JDOC.

Updated Nov 19, 2026

JDOC vs QAAGZX side by side

JDOCQAAGZX
TypeETFETF
Fund familyJ.P. MorganT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.65%0.86%
Annual cost per $10k$65$86
10-yr cost on $10k (prospectus)$810$1,061
Max front loadNoneNone
12b-1 fee—0%
1-yr return+14.9%+18.1%
5-yr return (annualized)—+4.1%
10-yr return (annualized)—+9.0%
Best quarter+11.3%+23.4%
Worst quarter−11.9%−15.8%
Net assets (fund)$9.1M$751.7M
Number of holdings61277
Portfolio turnover92%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearJDOCQAAGZXDifference
2025+14.9%+18.1%−3.2%
2024−0.6%+1.7%−2.3%

Source: Fund prospectus bar charts

Holdings overlap

13 of JDOC's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingJDOCQAAGZX
AbbVie, Inc.7.85%5.12%
Eli Lilly & Co.7.76%14.06%
UnitedHealth Group, Inc.5.85%5.88%
Merck & Co., Inc.4.82%4.00%
Johnson & Johnson4.82%6.64%
Thermo Fisher Scientific, Inc.3.73%2.53%
Bristol-Myers Squibb Co.3.57%2.12%
Abbott Laboratories3.11%1.91%
CVS Health Corp.2.83%0.93%
Stryker Corp.2.23%1.78%
Danaher Corp.2.16%1.44%
Intuitive Surgical, Inc.1.93%1.89%
Cardinal Health, Inc.1.51%1.04%

Source: SEC Form N-PORT

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between JDOC and QAAGZX?
JDOC (JPMorgan Healthcare Leaders ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 58% by weight. But QAAGZX is far broader, holding 277 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
Which is cheaper, JDOC or QAAGZX?
JDOC has the lower expense ratio (0.65%).
Should I own both JDOC and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.